Barclays Cuts Fortrea (NASDAQ:FTRE) Price Target to $21.00

Fortrea (NASDAQ:FTRE – Free Report) had its target price lowered by Barclays from $30.00 to $21.00 in a research note released on Tuesday morning, Benzinga reports. The brokerage currently has an equal weight rating on the stock. A number of other analysts also recently weighed in on the company. The Goldman Sachs Group assumed coverage […]

Leave a Reply

Your email address will not be published.

Previous post Roth Mkm Cuts D-Wave Quantum (NYSE:QBTS) Price Target to $2.00
Next post Cidara Therapeutics (NASDAQ:CDTX) Earns Buy Rating from Needham & Company LLC